Navigation Links
UW study: Sleep apnea associated with higher mortality from cancer

Madison, Wis. and San Francisco Sleep-disordered breathing (SDB), commonly known as sleep apnea, is associated with an increased risk of cancer mortality, according to a new study.

While previous studies have associated SDB with increased risks of hypertension, cardiovascular disease, depression, and early death, this is the first human study to link apnea with higher rate of cancer mortality. Lead author Dr. F. Javier Nieto, chair of the department of population health sciences at the UW School of Medicine and Public Health, says the study showed a nearly five times higher incidence of cancer deaths in patients with severe SDB compared to those without the disorder, a result that echoes previous findings in animal studies.

"Clearly, there is a correlation, and we are a long way from proving that sleep apnea causes cancer or contributes to its growth," says Nieto, an expert in sleep epidemiology. "But animal studies have shown that the intermittent hypoxia (an inadequate supply of oxygen) that characterizes sleep apnea promotes angiogenesisincreased vascular growth--and tumor growth. Our results suggest that SDB is also associated with an increased risk of cancer mortality in humans."

Dr. Nieto will present his study May 20 at the American Thoracic Society 2012 International Conference in San Francisco. It will be published in American Journal of Respiratory and Critical Care Medicine.

The team of University of Wisconsin-Madison investigators led by Nieto conducted this research in collaboration with Dr. Ramon Farr, professor of physiology at University of Barcelona, Spain. In a separate study also presented at the ATS conference, Dr. Farr's group showed that the effect of intermittent hypoxia on cancer growth is considerably stronger in lean mice than in obese mice.

The Wisconsin researchers examined 22-year mortality data on 1,522 subjects from the Wisconsin Sleep Cohort. This cohort is a longitudinal, community-based epidemiology study of sleep apnea and other sleep problems that begun in 1989 under the leadership of Dr. Terry Young, also a member of the UW population health sciences faculty. The cohort began was a random sample of Wisconsin state employees.

The participants undergo overnight sleep studies that include polysomnography an all-night recording of sleep and breathing and many other tests at four-year intervals. The studies are conducted in a specially designed unit at the federally funded UW Institute for Clinical and Transitional Research Center (ICTR).

After adjustment for age, sex, body mass index, and smoking, Nieto's study found that both all-cause and cancer mortality were associated with the presence and severity of SDB in a dose-response fashion. People with severe SDB died of cancer at a rate 4.8 times higher than people with no sleep breathing problems.

These associations were similar after excluding the 126 subjects who had used continuous positive airway pressure and were stronger among non-obese subjects than obese subjects.

"In our large population-based sample, SDB was associated with an elevated risk of cancer mortality," concluded Dr. Nieto. "Additional studies are needed to replicate these results. If the relationship between SDB and cancer mortality is validated in further studies, the diagnosis and treatment of SDB in patients with cancer might be indicated to prolong survival."


Contact: Susan Lampert Smith
University of Wisconsin-Madison

Related medicine news :

1. OHSU study: Misdiagnosis of MS is costing health system millions per year
2. Study: Kids Who Sleep in Parents Bed Less Likely to Be Overweight
3. Study: More Pre-Teens Get Vaccines When Middle Schools Require Them
4. Study: No link between depression, nasal obstruction
5. Study: Insomnia takes toll on tinnitus patients
6. Study: Women not getting enough exercise; at risk of developing metabolic syndrome
7. Study: Low bone density medications may have protective effect on endometrial cancer
8. Study: US tobacco-control efforts prevented nearly 800,000 cancer deaths between 1975 and 2000
9. Study: Sleep gets better with age, not worse
10. Study: Over 100,000 Californians likely to miss out on health care due to language barriers
11. Study: No Significant Rise in Seizure Risk From Common Kids Vaccine
Post Your Comments:
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... at the 7th Annual 2015 Golden Bridge Business Awards under the New Products ... a zero capex web based sample management software that helps labs ...
(Date:12/1/2015)... , ... December 01, 2015 , ... ... medical images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the ... North America Annual Meeting from November 29 to December 4, 2015. , ...
(Date:12/1/2015)... ... December 01, 2015 , ... The importance of ... is the focus of numerous abstracts accepted for presentation here, at the 101st ... Nine abstracts highlight the use of Volpara Solutions’ quantitative breast imaging software tools ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... their independence is everything. That is why Hollister Incorporated has launched the VaPro ... offer this next product in the VaPro touch free catheter portfolio,” said Michael ...
(Date:12/1/2015)... Francisco, CA (PRWEB) , ... December 01, 2015 ... ... Behavioral Health Center of Excellence (BHCOE) today announced that the organization has awarded ... in San Francisco, with a Distinguished Award. The award celebrates exceptional special needs ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Building on ... Johnson & Johnson (NYSE: JNJ ) today ... Pharmaceutical Companies to significantly reduce the burden of ... up 74 percent of new HIV infections among ... World AIDS Day, these new initiatives include collaborations ...
(Date:12/1/2015)... 01, 2015 ... addition of the "2016 Europe ... E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, ... their offering. --> ... the "2016 Europe Enteric Disease ...
(Date:12/1/2015)... Relmada Therapeutics, Inc. (OTCQB: RLMD), a clinical-stage company ... today that the company will present at the LD Micro ... the Luxe Sunset Boulevard Hotel in Los Angeles, ... Therapeutics, will present on Thursday, December 3, at 9:00 am ... Please register at least 10 minutes prior to the start ...
Breaking Medicine Technology: